Current Research in Biotechnology (CRBIOTECH), the new frontline biotech research golden open access journal by Elsevier, features in its first issue ten highly interesting articles excellently illustrating the contemporary diversity of the biotech field. Well aligning with the broad scope of the journal, the first published articles cover various topics from the areas of biomaterials development, genome editing, biosensors, nutrition and health optimization, molecular mechanisms deconvolution, monoclonal antibody technology research, biotech applications for environmental waste recycling, bioproduction technologies, bioassays development and validation, and even overall biotech research landscape analysis. The excellent quality of the so far published manuscripts, in combination with the strong attention immediately provoked in both the research communities and the general public, provide clear indications that CRBIOTECH is well on its way to become a sector-leading journal.
Atanas G. Atanasov, Cardioprotection by black pepper, genome edited crops safety, mobile-based inflammation assay, and other biotech research updates, Current Research in Biotechnology, Volume 1, 2019, Pages i-ii, https://doi.org/10.1016/j.crbiot.2019.11.002
Cardioprotection by black pepper, genome edited crops safety, mobile-based inflammation assay, and other biotech research updates https://t.co/hBNnEdS8zz #CRBIOTECH #Biotech #Biotechnology #INPST https://t.co/yPi76kqeUC— INPST (@_INPST) December 14, 2019
CC @erlesen @grawoig @HealthyFellow @Devkota_HP pic.twitter.com/nCnsnVgRGt
The International Natural Product Sciences Taskforce (INPST) maintains up-to-date lists with conferences, grants and funding opportunities, jobs and open positions, and journal special issues with relevance for the area of phytochemistry and food chemistry, pharmacology, biotechnology, medicine and pharmacognosy research, and natural product science.